StockNews.AI
LSAK
StockNews.AI
1 min

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lesaka Technologies, Inc. - LSAK

1. Pomerantz LLP is investigating Lesaka for potential securities fraud. 2. Lesaka’s financial statements for multiple quarters require restatement. 3. Stock price fell sharply following the news of potential fraud. 4. Investors can join the class action against Lesaka for claims. 5. The investigation may impact Lesaka's reputation and share performance.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The news of securities fraud investigation and financial restatement severely harms investor trust. Historical examples show similar situations often led to significant long-term price declines due to loss of credibility.

How important is it?

The actions taken against Lesaka may lead to significant financial losses for investors, making this a critical issue. Since LSAK is directly involved, the implications from this investigation are highly pertinent.

Why Short Term?

The immediate fallout from the investigation and restatement will likely reduce stock value. However, longer-term effects depend on resolution and management's response.

Related Companies

AAPLTSLAGOOGL
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Lesaka Technologies, Inc. (“Lesaka” or the “Company”) (NASDAQ: LSAK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lesaka and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On September 10, 2025, Lesaka disclosed in a filing with the U.S. Securities and Exchange Commission (“SEC”) that the Audit Committee of its Board of Directors had “concluded that the Company’s unaudited condensed consolidated financial statements for the quarters ended September 30, 2024, December 31, 2024, and March 31, 2025, respectively, included in the Company’s Quarterly Reports on Form 10-Q for the quarters ended September 30, 2024, December 31, 2024, and March 31, 2025, respectively (the “Quarterly Reports”), should be restated, and that such unaudited condensed financial statements should no longer be relied upon, due to the Company’s re-evaluation of the classification of certain revenue that has been reported as an agent rather than as principal, and related cost of goods sold.”  On this news, Lesaka’s stock price fell sharply during intraday trading on September 11, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.    CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News